Funding
Dr. Mahal is funded by the Prostate Cancer Foundation (PCF) and the American Society for Radiation Oncology (ASTRO), the Department of Defense, and the Sylvester Comprehensive Cancer Center. Dr. Franco is funded in part through a Diversity Supplement from the Center to Reduce Cancer Health Disparities, National Cancer Institute (NCI), and National Institutes of Health (NIH). Dr. Chino, Dr. Lapen, and Dr. Dee are funded in part through the NIH/NCI support grant P30 CA008748.
Author information
Authors and Affiliations
Contributions
NS, ECD, and FC had full access to all data and had final responsibility for the decision to submit this article for publication. Concept and design: all authors; acquisition, analysis, and interpretation of data: all authors; drafting of the manuscript: NS, TN and ECD; critical revision of the manuscript for important intellectual content: all authors; statistical analysis: NS and ECD.
Corresponding author
Ethics declarations
Disclosure
Dr. Duma has provided consulting/advisory services for Pfizer, Merck, BMS, AstraZeneca, Genentech, Neogenomics, Janssen, BI oncology, and Inivata. No conflict of interest relevant to this submission were reported.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Swami, N., Nguyen, T., Dee, E.C. et al. ASO Visual Abstract: Disparities in Primary-Stage Breast Cancer at Presentation Among Hispanic Subgroups. Ann Surg Oncol 29, 7990–7991 (2022). https://doi.org/10.1245/s10434-022-12375-6
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12375-6